US Medical Care: $234K Lifetime Cost for 1.3 Years of Health Gain

U.S. Medical care has demonstrably improved over the past two decades, extending health spans by an average of 1.3 years. However, these gains haven’t come cheaply – and the value of those gains varies significantly depending on the specific disease or condition being treated. A modern study published in Value in Health reveals that lifetime medical spending has increased by $234,000 per person during that period, translating to roughly $182,000 for each additional healthy year of life achieved.

Researchers at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School of Medicine undertook a comprehensive analysis, examining changes in 132 causes of disease across all age groups between 1996 and 2016. Their goal was to assess what Americans are actually receiving in return for the substantial and continually rising costs of healthcare. The study, led by senior author Marcia Weaver, Ph.D., highlights a critical point: the issue isn’t simply how much the U.S. Spends on healthcare, but where those dollars are directed and the resulting impact on health outcomes.

Uneven Returns on Investment

The analysis revealed a stark contrast in value across different conditions. Investments in resources for roughly 60% of diseases – including ischemic heart disease, stroke, and HIV/AIDS – yielded substantial health improvements at a relatively modest cost. For example, advancements in medications, medical devices, and emergency care for ischemic heart disease added, on average, a quarter of a healthy year to Americans’ lives at a cost of approximately $63,000 per healthy year gained. HIV/AIDS treatments proved particularly cost-effective, delivering significant increases in both survival and quality of life at a low cost of $9,300 per healthy year gained.

Interestingly, 19 causes of illness (14%) demonstrated a particularly favorable outcome: increases in health-adjusted life expectancy (HALE) accompanied by decreases in lifetime spending. Breast cancer is one example, where advances in screening and treatment have extended health spans whereas simultaneously reducing overall lifetime costs, reflecting a shift towards less invasive and more effective care.

Where Spending Doesn’t Translate to Health

Conversely, the study identified seven causes of illness (5%) where both HALE and lifetime spending decreased, such as those related to alcohol use disorders. HALE declined for an additional 26 causes (20%) while lifetime spending increased, a pattern observed with chronic kidney disease and drug use disorders. Notably, drug use disorders significantly diminished the overall value of U.S. Healthcare during the study period.

“Disease-level spending estimates provide a foundation for identifying patterns in health care spending and understanding how those patterns relate to health outcomes,” explained co-author Abe Dunn, Ph.D., Assistant Chief Economist at the United States Bureau of Economic Analysis.

The Impact of Timing and Early Intervention

The researchers also observed a temporal pattern in spending and health improvements. For many diseases, healthcare spending tended to increase earlier in life, with the corresponding health benefits manifesting years or even decades later. Recalculating the value of healthcare starting at age 65 revealed a more favorable cost-benefit ratio – approximately $92,000 per healthy year gained, compared to $182,000 when calculated from birth. This underscores the potential long-term benefits of early investments in prevention and treatment, particularly for chronic conditions like diabetes and heart disease.

Shifting the Focus: Value-Based Healthcare

The study’s findings suggest that efforts to control healthcare costs should move away from broad, across-the-board spending cuts and instead prioritize improving access to care for conditions and interventions that demonstrably improve health. Further research and innovation are crucial for addressing conditions that drive up costs without yielding corresponding health benefits. According to Prof. Weaver, “Better alignment of spending with health outcomes could significantly improve the overall value of U.S. Health care, ultimately saving lives, improving quality of life, and making more effective use of limited resources.”

The national health expenditure (NHE) grew 7.2% to $5.3 trillion in 2024, according to a fact sheet released by the Centers for Medicare & Medicaid Services (CMS). This represents $15,474 per person, accounting for 18.0% of the Gross Domestic Product (GDP). CMS data shows Medicare spending grew 7.8% to $1,118.0 billion, while Medicaid spending increased 6.6% to $931.7 billion. Private health insurance accounted for 31% of total NHE, at $1,644.6 billion.

Looking Ahead: A Focus on Value

The implications of this research extend beyond cost containment. It calls for a fundamental re-evaluation of how healthcare resources are allocated, prioritizing interventions that deliver the greatest health benefits for the investment. Future research should focus on identifying and addressing the specific factors driving up costs without improving health outcomes, and on developing innovative strategies to maximize the value of healthcare spending. This includes a deeper understanding of the social determinants of health and the role of preventative care in improving long-term health outcomes. The study’s authors emphasize that a shift towards value-based healthcare – where reimbursement is tied to quality and outcomes – is essential for creating a more sustainable and equitable healthcare system.

Calvin Ackley et al, The Value of Healthcare in the United States: Changes in Lifetime Spending and Health-Adjusted Life Expectancy, 1996 to 2016, Value in Health (2026). DOI: 10.1016/j.jval.2026.01.008

Provided by Institute for Health Metrics and Evaluation